[1] |
QIAO Hongliang, DING Ning, DENG Kaihong, LIU Binbin, DONG Chuanjiang, CHEN Xiaobo, ZOU Lili.
New progress in research on novel control strategies for methicillin-resistant staphylococcus aureus infection
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(6): 676-687.
|
[2] |
ZHANG Peng, WANG Zishu, XU Lihong, YIN Xiangnan, HU Wen, CHEN Chunlin.
Synergistic antibacterial effect of ursolic acid combined with fusidic acid on Staphylococcus aureus
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(6): 608-613.
|
[3] |
XU Jia, HUANG Qi, YANG Zhiling .
Evaluation of clinical rationality of linezolid in our hospital in 2016
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(1): 110-115.
|
[4] |
JIANG Cheng, LV Jiangang, LI Fangqiong, YE Zuowu, LU Chunfang, LI Gonghua.
Correlation between detection rate of clindamycin-resistant Staphylococcus aureus and utilization of antibacterial drugs
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(4): 439-442.
|
[5] |
WANG Hai-hua, ZHANG Gen-bao, MIN Zhi-xue, HUANG Lu, CUI Feng-juan.
Study on analgesic effect of active component from crude cobra venom in Wannan Area
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2013, 18(10): 1093-1099.
|
[6] |
HUA Jun-yan, TIAN Wei-qiang, ZHU Ya-yan, YU Hui-kang.
Efficacy and plasma concentration analysis of Vancomycin in the treatment of methicillin-resistant Staphylococcus aureus infection
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2010, 15(6): 673-677.
|
[7] |
LIANG Bei-bei, WANG Rui, BAI Nan, CAI Yun.
Mutant prevention concentrations study of linezolid and vancomycin against methicillin-resistant staphylococcus aureus isolates
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2010, 15(3): 251-254.
|
[8] |
SONG Xiu-jie, JU Hong-mei, YU Xu-hong, LIN De-feng, WANG Rui, LIU You-ning.
In vitro activities of levofloxacin in combination with fosfomycin against staphylococcus aureus
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2010, 15(12): 1388-1394.
|
[9] |
MA Jing-jing, LI Jin-heng, CHENG Lu.
Study on the CYP2C9 and CYP2C19 genetic polymorphism in Chinese subjects by using 3-dimense polyacrylamide gel-based microarray platform
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2009, 14(9): 966-973.
|
[10] |
CHEN Dong-yun, PAN Xue-bing, JI Zhao-ning.
Anticancer activity of extractive purified from Agkistrodon acutus Venom in vitro
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2009, 14(1): 37-41.
|
[11] |
PAN Xue-bing, CHEN Dong-yun, HUAI Jian-guo, JI Zhao-ning.
Purification of antineoplasmic activity protein from the venom of Wannan Agkistrodon and the study in vitro
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2008, 13(9): 991-995.
|
[12] |
WANG Hui, MENG Jing-ru, CHEN Tao, JIA Ming, HE Gong-hao, MA Xue, LUO Xiaoxing.
Reversal of antibiotic resistance methicillanin-resistant staphylococcus aureus by polyethyleneimine-phosphothioate oligodeoxynucleotide nanometer particle
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2008, 13(1): 31-35.
|
[13] |
CUI Jun-chang, LIU You-ning, WANG Rui, TONG Wei-hang, LIANG Bei-bei.
Correlation of levofloxacin pharmacokinetic/pharmacodynamic parameters with selection of staphylococcus aureus resistance
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2007, 12(9): 989-992.
|
[14] |
LI Zhao-xia, LIU You-ning, WANG Rui, TONG Wei-hang, CHENG Shi-hu.
Preliminary study for narrowing mutant selection window of staphylococcus aureus by combination of levofloxacin and Vancomycin in vitro
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2007, 12(8): 911-914.
|
[15] |
CUI Jun-chang, LIU You-ning, WANG Rui, TONG Wei-hang, LI Zhao-xia.
Development of tissue cage infection model and study of efficacy of levofloxacin in treatment of staphylococcus aureus infection
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2007, 12(3): 291-294.
|